Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Dec 18;158(1):252–264.e2. doi: 10.1016/j.jtcvs.2018.12.001

Table 6.

Perioperative outcomes after propensity matching

Characteristic Open approach (n = 50) VATS approach (n = 50) P-value
30-day mortality (n, %) 3 (6) 2 (4) 1.00
90-day mortality (n, %) 4 (8) 7 (14) 0.53
Length of hospitalization, median (IQR), days 5 (4-6) 5 (4-6) 0.10
Chest tube duration, median (IQR)12, days 2 (1-2) 1 (1-2) 0.04
Estimated blood loss (mean ± SD) (mL)13 378 ± 221 395 ± 408 0.48
Length of surgery (mean ± SD) (min)14 239 ± 92 272 ± 93 0.14
Acute pain syndrome (n, %)15 5 (10) 4 (8) 0.75
Lymph nodes dissected (mean ± SD)16 12.9 ± 9.8 20 ± 15.5 0.01
Lymph node stations dissected (mean ± SD) 4.8 ± 2.3 4.9 ± 4.1 0.56
N2 stations dissected (mean ± SD) 3.7 ± 1.6 4.9 ± 1.9 0.001
Overall morbidity (n, %) 12 (24) 14 (28) 0.65
 Atrial fibrillation 10 (20) 11 (22) 0.81
 Bronchopleural fistula 1 (2) 1 (2) 1.00
 Empyema 0 (0) 0 (0) 1.00
 Pneumonia 3 (6) 4 (8) 1.00
 Pericardial effusion 1 (2) 3 (6) 0.62
 Myocardial infarction 0 (0) 0 (0) 1.00
12

Data only available for 79 of 100 patients (open: n = 41, VATS: n = 38)

13

Data only available for 68 of 100 patients (open: n = 19, VATS: n = 49)

14

Data only available for 77 of 100 patients (open: n = 28, VATS: n = 49)

15

Data only available for 99 of 100 patients (open: n = 50, VATS: n = 99)

16

Data only available for 90 of 100 patients (open: n = 44, VATS: n = 46)